As of 2024-12-11, the Relative Valuation of Fortress Biotech Inc (FBIO) is (48.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.12 USD, the upside of Fortress Biotech Inc based on Relative Valuation is -2404.8%.
The range of the Relative Valuation is (49.85) - (55.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.4x - 44.7x | 35.0x |
| Forward P/E multiples | 20.3x - 31.5x | 20.6x |
| Fair Price | (49.85) - (55.33) | (48.86) |
| Upside | -2451.3% - -2709.9% | -2404.8% |
| Date | P/E |
| 2024-12-09 | -1.28 |
| 2024-12-06 | -1.17 |
| 2024-12-05 | -1.17 |
| 2024-12-04 | -1.24 |
| 2024-12-03 | -1.25 |
| 2024-12-02 | -1.31 |
| 2024-11-29 | -1.21 |
| 2024-11-27 | -1.04 |
| 2024-11-26 | -1.05 |
| 2024-11-25 | -0.96 |
| 2024-11-22 | -0.92 |
| 2024-11-21 | -0.89 |
| 2024-11-20 | -0.89 |
| 2024-11-19 | -0.90 |
| 2024-11-18 | -0.84 |
| 2024-11-15 | -0.81 |
| 2024-11-14 | -0.89 |
| 2024-11-13 | -0.94 |
| 2024-11-12 | -0.97 |
| 2024-11-11 | -1.00 |
| 2024-11-08 | -0.97 |
| 2024-11-07 | -0.98 |
| 2024-11-06 | -1.00 |
| 2024-11-05 | -1.00 |
| 2024-11-04 | -0.98 |
| 2024-11-01 | -1.08 |
| 2024-10-31 | -1.08 |
| 2024-10-30 | -1.10 |
| 2024-10-29 | -1.15 |
| 2024-10-28 | -1.15 |
| 2024-10-25 | -1.05 |
| 2024-10-24 | -0.98 |
| 2024-10-23 | -1.01 |
| 2024-10-22 | -1.03 |
| 2024-10-21 | -1.01 |
| 2024-10-18 | -1.04 |
| 2024-10-17 | -1.03 |
| 2024-10-16 | -1.00 |
| 2024-10-15 | -0.98 |
| 2024-10-14 | -0.96 |
| 2024-10-11 | -0.93 |
| 2024-10-10 | -0.90 |
| 2024-10-09 | -0.90 |
| 2024-10-08 | -0.87 |
| 2024-10-07 | -0.90 |
| 2024-10-04 | -0.93 |
| 2024-10-03 | -0.92 |
| 2024-10-02 | -0.89 |
| 2024-10-01 | -0.81 |
| 2024-09-30 | -0.82 |